microdosing glp 1 for hashimoto's EllieMD What Is Microdosing GLP-1s And
Description
95% CI 0.09, 0.1), GLP-1 RAs/metformin (WMD: 0.31
This highlights the importance of the need for further research to understand the underlying mechanisms of these changes

Although patients at risk for diabetes (ie, prediabetes, defined as a hemoglobin A1C 5.7% to 6.4% or a fasting blood glucose level 100 to 125 mg/dL) were included in FDA registration trials of Saxenda or Wegovy, prediabetes is not an FDA indication for any GLP-1 agonist
However, most patients find it convenient to inject the medication on the same day each week, and some prefer to do so before or after a meal

It's all about showing a consistent effort towards improving your health
